A Long-term Study of DE-117 Ophthalmic Solution Monotherapy and Concomitant Use of DE-117 Ophthalmic Solution With Timolol Ophthalmic Solution in Patients With OAG or OH: RENGE Study

Clinical trial NCT02822729 · COMPLETED

Trial details

NCT number: NCT02822729
Sponsor: Santen Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Open Angle Glaucoma or Ocular Hypertension

Start date: 2016-07-01
Primary completion: 2017-11-09
Enrollment: 125

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.